Prazosin kinetics and effectiveness in renal failure

Area of Science:

• Pharmacology
• Nephrology
• Cardiology

Background:

• Prazosin is an alpha-1 blocker used to treat hypertension.
• The impact of renal function on prazosin pharmacokinetics and efficacy is not fully understood.

Purpose of the Study:

• To evaluate prazosin pharmacokinetics and blood pressure response in hypertensive patients with normal and impaired renal function.
• To determine the optimal dosage range for prazosin in patients with varying degrees of renal function.

Main Methods:

• Single and repeated doses of prazosin were administered to 17 hypertensive patients (5 with normal, 12 with impaired renal function).
• Blood samples were collected for prazosin assay after a single dose and at steady-state.
• Blood pressure was recorded concurrently with blood draws.

Main Results:

• Prazosin absorption and elimination kinetics were not significantly altered by impaired renal function.
• No drug accumulation was observed in patients with impaired renal function upon repeated dosing.
• Antihypertensive efficacy was significantly greater with prazosin doses of 3-8 mg/day compared to 9-20 mg/day.
• No direct correlation was found between peak plasma prazosin levels and antihypertensive response.

Conclusions:

• Impaired renal function does not affect prazosin absorption or elimination.
• Prazosin is effective and safe for hypertensive patients with renal impairment.
• The optimal antihypertensive dosage range for prazosin, with or without diuretics or dialysis, is 3 to 8 mg/day.